Skip navigation
Skip navigation

Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future

Pokorny, Adrian M J; Chin, Venessa; Nagrial, Adnan M; Yip, Desmond; Chantrill, Lorraine


Metastatic pancreatic ductal adenocarcinoma (mPDAC) is a lethal disease with a poor 5-year survival. Systemic treatments can be used to control symptoms and prolong life. Cytotoxic chemotherapies are commonly administered, with combination treatments, such as fluorouracil, folinic acid, irinotecan and oxaliplatin (FOLFIRINOX) or nab paclitaxel and gemcitabine showing the largest clinical benefits. Newer genomic classifications of PDAC may provide a rationale for targeted therapies or...[Show more]

CollectionsANU Research Publications
Date published: 2018
Type: Journal article
Source: Internal Medicine Journal
DOI: 10.1111/imj.13810


File Description SizeFormat Image
01_Pokorny_Metastatic_pancreatic_ductal_2018.pdf450.17 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator